Backed by a $1.2 million round of funding, Center City-based NeuroFlow will look to meet the “tremendous” market traction its mental health patient engagement platform has been gaining among healthcare providers, CEO Chris Molaro says.
Though the company raised a $1.25 million seed round last fall, this funding round — led by New Brunswick, N.J.-based angel investor group NJ JumpStart — isn’t yet a Series A. Through a spokesman, the company called the funding a “post-seed” round, which also had participation from previous investors including Independence Blue Cross, Chestnut Street Venturesand Ben Franklin Technology Partners.
Currently a team of 13, the company will used the funding to expand on its current technology, under use by individual mental health practitioners and hospital systems, as well as add key hires by the end of the year.
Read the full article here.